Emergency Available Drugs in Markets to Treat COVID-19

Abstract

Our current study is focused on emergency available drug in market to treat COVID-19 a viral infection that produces pneumonia and respiratory disorder. By pharmacology knowledge base treating viral-respiratory infection and immune inflammation, which posses’ direct effect against corona virus (COVID-19) the different antibiotics were evaluated from market on COVID-19 symptoms which includes Provas 100ml, Injections: Azithma 500mg, Oxidil 1gm, Gen-M 180mg and Bejectal. The Pladex 100ml, Infusion R/L 500ml, Tablet Panadol Extra, Syrup Pelton – V and Capsule Vibramycin in laboratory CatA21 (LRHP1) and CatB20 (AMCMDN2) for 1 to 3 days treatment and the Patients ages range from 37-56 and their recovering ratio calculated from the laboratory test by immune system and physical health comparison which were recorded as 95% with positive rate with a good health.